Hilleman Laboratories’ long-serving CEO, Davinder Gill, is moving on after an eventful stint at the helm and will hand over the reins to former Takeda Pharmaceutical Co. Ltd. executive Raman Rao.
Gill, who has been Hilleman’s CEO since 2012, has steered the global vaccine R&D organization to some important milestones including...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
